1. Letter From the Commissioner’s Office at the US FDA

   • John A. Vernon

   EditorialNotes 25 November 2012 Pages: 1 - 2

2. Rates and Probabilities in Economic Modelling

   • Rachael L. Fleurence
   • Christopher S. Hollenbeak

   Practical Application 25 November 2012 Pages: 3 - 6

3. Reducing the Societal Burden of Depression

   • Julie M. Donohue
   • Harold Alan Pincus

   Review Article 25 November 2012 Pages: 7 - 24

   

4. Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants

   • Judith E. Bosmans
   • Oscar H. Brook
   • Maurits W. van Tulder

   Original Research Article 25 November 2012 Pages: 25 - 37

   

5. A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK

   • Dominic P. Tilden
   • Segundo Mariz
   • Alexander Diamantopoulos

   Original Research Article 25 November 2012 Pages: 39 - 54

   

6. Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children

   • Mark J. C. Nuijten
   • Wolfgang Wittenberg
   • Maximilian Lebmeier

   Original Research Article 25 November 2012 Pages: 55 - 71

   

7. Time Preferences for Health in Northern Tanzania

   • Bjarne Robberstad
   • John Cairns

   Original Research Article 25 November 2012 Pages: 73 - 88